Allergan gets EU recommendation on new use of eye drug
July 25, 2014 at 08:46 AM EDT
July 25 (Reuters) - Allergan Inc, known best for its Botox wrinkle treatment, said on Friday that European Union regulators had recommended use of its eye drug Ozurdex be extended to treat patients with diabetic macular edema.